he main manuscript of the REUMAVID project, “Assessment of the Impact of the COVID-19 from the Perspective of Patients with Rheumatic and Musculoskeletal Diseases in Europe. Results from the REUMAVID study (Phase 1).” has been accepted for publication in the RMD Open, an official scientific journal of the European League Against Rheumatism (EULAR). This is an important milestone for the REUMAVID working group the open Access format of RMD Open will allow for wide dissemination of the study key messages to the scientific community worldwide.
The manuscript covers how provides evidence on how the COVID-19 pandemic has affected European rheumatic and musculoskeletal disease patients’ physical and psychological health, well-being and lifestyle habits, access to healthcare and treatment as well as access to information and supportive services from the patient’s perspective. Results show that, throughout the first wave of the COVID-19 pandemic, patients experienced disruptions in access to healthcare services, poor lifestyle habits and worsening physical health, well-being and mental health. The full length manuscript can be consulted here: https://rmdopen.bmj.com/content/7/1/e001546
This is just the first of many other scientific works that are currently developing by the REUMAVID working group that more specifically assess country differences, gender differences, wellbeing determinants during lockdown and fears and hopes about the pandemic, among others.
